4.8 Article

Dominant Lethal Pathologies in Male Mice Engineered to Contain an X-Linked DUX4 Transgene

期刊

CELL REPORTS
卷 8, 期 5, 页码 1484-1496

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2014.07.056

关键词

-

资金

  1. NIH [R01 AR055685, R01 AR055299, U01 HL100407, T32-AR07612, R01 HL68802, R01 HL103773, R01 HD053889]
  2. Dr. Bob and Jean Smith Foundation
  3. Muscular Dystrophy Centre Core Laboratory [P30 AR0507220]
  4. Muscular Dystrophy Association [MDA 4361]
  5. FSH Society [FSHS-MGBF-016]
  6. [K02-AG036827]

向作者/读者索取更多资源

Facioscapulohumeral muscular dystrophy (FSHD) is an enigmatic disease associated with epigenetic alterations in the subtelomeric heterochromatin of the D4Z4 macrosatellite repeat. Each repeat unit encodes DUX4, a gene that is normally silent in most tissues. Besides muscular loss, most patients suffer retinal vascular telangiectasias. To generate an animal model, we introduced a doxycycline-inducible transgene encoding DUX4 and 30 genomic DNA into a euchromatic region of the mouse X chromosome. Without induction, DUX4 RNA was expressed at low levels in many tissues and animals displayed a variety of unexpected dominant leaky phenotypes, including male-specific lethality. Remarkably, rare live-born males expressed DUX4 RNA in the retina and presented a retinal vascular telangiectasia. By using doxycycline to induce DUX4 expression in satellite cells, we observed impaired myogenesis in vitro and in vivo. This mouse model, which shows pathologies due to FSHD-related D4Z4 sequences, is likely to be useful for testing anti-DUX4 therapies in FSHD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据